Phibro Animal Health Corporation

Company Profile

Phibro Animal Health Corporation had its IPO on 2014-04-11 under the ticker symbol PAHC.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Phibro Animal Health Corporation has a staff strength of 1,920 employees.

Stock update

Shares of Phibro Animal Health Corporation opened at $12.61 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $12.59 - $12.87, and closed at $12.68.

This is a -0.24% slip from the previous day's closing price.

A total volume of 94,722 shares were traded at the close of the day’s session.

In the last one week, shares of Phibro Animal Health Corporation have slipped by -11.82%.

Phibro Animal Health Corporation's Key Ratios

Phibro Animal Health Corporation has a market cap of $514.80 million, indicating a price to book ratio of 1.9562 and a price to sales ratio of 0.5463.

In the last 12-months Phibro Animal Health Corporation’s revenue was $977.89 million with a gross profit of $298.24 million and an EBITDA of $104.40 million. The EBITDA ratio measures Phibro Animal Health Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Phibro Animal Health Corporation’s operating margin was 7.35% while its return on assets stood at 4.72% with a return of equity of 11.97%.

In Q2, Phibro Animal Health Corporation’s quarterly earnings growth was a positive 57% while revenue growth was a negative 0.1%.

Phibro Animal Health Corporation’s PE and PEG Ratio

Forward PE

14.9254

Trailing PE

15.6914

PEG

1.6618

Its diluted EPS in the last 12-months stands at $0.81 per share while it has a forward price to earnings multiple of 14.9254 and a PEG multiple of 1.6618. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Phibro Animal Health Corporation’s profitability.

Phibro Animal Health Corporation stock is trading at a EV to sales ratio of 0.9695 and a EV to EBITDA ratio of 8.152. Its price to sales ratio in the trailing 12-months stood at 0.5463.

Phibro Animal Health Corporation stock pays annual dividends of $0.48 per share, indicating a yield of 3.82% and a payout ratio of 39.34%.

Balance sheet and cash flow metrics

Total Assets

$971.40 million

Total Liabilities

$176.00 million

Operating Cash Flow

$-10282000.00

Capital Expenditure

$10.89 million

Dividend Payout Ratio

39.34%

Phibro Animal Health Corporation ended 2024 with $971.40 million in total assets and $0 in total liabilities. Its intangible assets were valued at $971.40 million while shareholder equity stood at $282.51 million.

Phibro Animal Health Corporation ended 2024 with $0 in deferred long-term liabilities, $176.00 million in other current liabilities, 4000.00 in common stock, $260.91 million in retained earnings and $53.27 million in goodwill. Its cash balance stood at $41.28 million and cash and short-term investments were $81.28 million. The company’s total short-term debt was $28,348,000 while long-term debt stood at $452.54 million.

Phibro Animal Health Corporation’s total current assets stands at $585.72 million while long-term investments were $11.09 million and short-term investments were $40.00 million. Its net receivables were $163.48 million compared to accounts payable of $73.85 million and inventory worth $277.57 million.

In 2024, Phibro Animal Health Corporation's operating cash flow was $-10282000.00 while its capital expenditure stood at $10.89 million.

Comparatively, Phibro Animal Health Corporation paid $0.39 in dividends in 2024.

Other key metrics

Current Trading Price

$12.68

52-Week High

$16.2242

52-Week Low

$11.4524

Analyst Target Price

$17

Phibro Animal Health Corporation stock is currently trading at $12.68 per share. It touched a 52-week high of $16.2242 and a 52-week low of $16.2242. Analysts tracking the stock have a 12-month average target price of $17.

Its 50-day moving average was $14.41 and 200-day moving average was $14.23 The short ratio stood at 6.13 indicating a short percent outstanding of 0%.

Around 54.3% of the company’s stock are held by insiders while 10126.5% are held by institutions.